Prostate cancer is the most commonly diagnosed cancer among men in 112 countries, and its prevalence is projected to double by 2040. Nationally implemented screening programs that measure ...

Sara Moniuszko is a health and lifestyle reporter at CBSNews.com. Previously, she wrote for USA Today, where she was selected to help launch the newspaper's wellness vertical. She now covers breaking ...

Using both PSMA PET and mpMRI before cognitive targeted biopsy improved specificity for clinically significant prostate cancer from 54.6% to 86.3%. For men undergoing evaluation for suspected prostate ...

Stockholm3-MRI population-based screening: Two-year outcomes comparing Stockholm3 and PSA. Predictive capability of combining ExoDx (EPI) and pre-biopsy prostate MRI in detecting clinically ...

To check for possible prostate cancer, physicians most often use prostate-specific antigen (PSA) tests and digital rectal exams (DREs). For a firm diagnosis, they use core needle biopsies. This page ...

News that former President Joseph Biden has advanced prostate cancer has revived long-standing questions about the benefits versus the harms of a blood test that screens for the most commonly ...

The clinical impact of germline variants in DNA repair genes in patients who underwent curative surgery for localized prostate cancer. Multivariable logistic regression model for predicting ...